top of page

Clinical Sites Network Alliance

BIOTrialMed has developed the Clinical Sites/PIs Network Alliance (CSNA), which contain 300+ top clinical research centers and experienced principal investigators globally. Aimed at optimizing the execution of clinical studies, these pre-qualified clinical centers and investigators leverage streamlined processes and offer quick study startup, increasing the success of a clinical study and lowering the study expenditures. 

Rare Disease Center

Our Rare Disease Center offers clinical and commercialization solutions for orphan drugs. We help develop regulatory, clinical and commercial strategies and help secure resources for your trial. 

 

Partnered with medical centers that focus on rare diseases in developing countries, we offer flexible and innovative solutions that recruit subjects and complete studies faster and reduce trial expenditures. 

Chronic_Care_Remote_Physiological_Monitoring_HealthViewX.png
WechatIMG23769.jpg

AI+ Clinical Trials

BIOTrialMed's AI-driven technologies streamline various aspects of clinical trials, from study design to data analysis and regulatory compliance. These technologies analyze vast amounts of data quickly and accurately, identifying patterns and insights that can optimize trial protocols and improve patient outcomes.

Key applications of AI+ clinical trial services:

  • Patient Recruitment and Retention

AI algorithms can analyze patient databases and electronic health records to identify eligible participants quickly. Predictive analytics help in targeting patient populations likely to adhere to trial protocols, thereby improving recruitment and retention rates.

  • Protocol Optimization

AI-driven simulations and predictive models assist in designing efficient trial protocols. By analyzing historical data and real-time inputs, AI helps optimize sample sizes, endpoints, and study duration, reducing costs and accelerating time-to-market.

  • Real-time Data Monitoring

AI-enabled tools continuously monitor incoming data for anomalies or trends, enabling early detection of issues and enhancing data quality. This proactive approach minimizes risks and ensures compliance with regulatory standards.

  • Personalized Medicine

AI algorithms analyze patient data to identify biomarkers and genetic profiles that can predict individual responses to treatments. This personalized approach supports the development of targeted therapies and improves overall trial success rates.

  • Risk Management and Compliance

AI platforms assist in navigating complex regulatory landscapes by ensuring adherence to protocols and guidelines. Automated reporting and audit trails enhance transparency and regulatory compliance throughout the trial process.

  • Predictive Analytics for Outcomes

AI models predict clinical outcomes based on various factors, facilitating informed decision-making and optimize trial success.

Comprehensive Processes Ensure Trials are Successful 

 

BIOTrialMed 的多学科团队由临床药理学专家、监管专家和医学专家组成,他们对模型结果进行解读,以提供临床见解并为监管策略提供依据

Picture1.png
Picture1.png
Picture1.png
Picture1.png
Picture1.png
Picture1.png
Picture1.png

丰富的治疗领域专业知识

BIOTrialMed 团队在肿瘤、疫苗、初级保健、医疗器械等多个治疗领域拥有丰富的经验
 

最新技术趋势和平台

BIOTrialMed 团队继续在新兴技术领域积累经验,包括基因治疗、免疫肿瘤学和新型传输平台

image.png
image.png

Efficient and flexible global team

BIOTrialMed offers highly customized solutions to meet our partners’ needs. We leverage our expertise and experience to efficiently design, prepare, execute, and deliver clinical results to meet the evolving demands in clinical research. Together with our academic and functional experts, we can provide you with guidance whether you are seeking esoteric or practical regulatory, medical, or clinical advice.

Full-process budget management and communication

BIOTrialMed closely collaborates with partners to ensure all our studies are delivered successfully on time, within budget, and are of the highest quality. Communication is prioritized, such that our partners receive detailed updates periodically. We provide comprehensive reports, metrics, and dashboards to ensure partners receive the right information at the right time to make informed decisions.

image.png
bottom of page